Podcast thumbnail for The 411 on a GLP-1

The 411 on a GLP-1

Claim This Podcast

by Novo Nordisk

6 episodes
Updated Inactive
Accepts GuestsHas SponsorsLocation 🇺🇸

Podcast Overview

Join series hosts Dr. Jim Gavin, Clinical Professor of Medicine at Emory University and Chief Medical Officer at Healing Our Village, in Atlanta, GA; Dr. Jennifer Goldman, Professor of Pharmacy at Massachusetts College of Pharmacy, in Boston, MA, and Clinical Pharmacist at Well Life Medical, in Peabody, MA, and other fellow leaders in the field of diabetes as they tackle some of the challenges we face when treating T2D. Topics of discussion include the disease state of T2D, the role of GLP-1 in glucose regulation, guidelines on early use of GLP-1 RAs in T2D treatment, as well as the mechanism of action, dosing and administration, efficacy and safety profiles, handling and storage, and education of patients and pharmacists for a once-daily GLP-1 RA for adults with T2D. This podcast series is sponsored by Novo Nordisk and is intended for clinicians.

Language

🇺🇲

Publishing Since

6/6/2022

1 verified contact email on file for The 411 on a GLP-1

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for Frequently Asked Questions About a GLP-1 RA Treatment Option for T2D

October 27, 2023

Frequently Asked Questions About a GLP-1 RA Treatment Option for T2D

What do you need to know about a once daily GLP-1 RA therapy for adults with T2D? Join experts in T2D Aaron King, MD, Helen Baron, MD, and Stephen Brunton, MD, FAAP, FRACGP, CDCES, as they discuss frequently asked questions regarding the use of a once daily treatment for adults with T2D with the goal of helping to provide answers. Key topics include dosing and administration, handling and storage, as well as efficacy and safety.

Episode thumbnail for Patient-Focused Care in T2D: The Pharmacist’s Role in GLP-1 RA Education

October 27, 2023

Patient-Focused Care in T2D: The Pharmacist’s Role in GLP-1 RA Education

What is the role of the pharmacist in patient- centered care of adults with type 2 diabetes (T2D)? Join pharmacist experts in T2D Jennifer Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP, Melody Hartzler, PharmD, BCACP, BC- ADM, AE-C, and Donald Nuzum, PharmD, BCACP, BC-ADM, CDCES, as they discuss education of patients and pharmacists on the pharmacokinetics, administration, dosing schedule and handling of a GLP-1 receptor agonist (GLP-1 RA). They will also consider when to use a GLP-1 RA, where they review clinical data on efficacy and safety of a GLP-1 RA, including in a trial when used as monotherapy vs placebo, a head-to-head study vs a DPP-4 inhibitor, and a cardiovascular outcomes study.

Episode thumbnail for Explore A Treatment Option to Improve Glycemic Control in Adults With T2D

October 23, 2023

Explore A Treatment Option to Improve Glycemic Control in Adults With T2D

Explore a treatment option to improve glycemic control in adults with T2D and when you should consider using a GLP-1 RA. Join experts in T2D Aaron King, MD, Davida Kruger, MSN, APRN-BC, and Javier Morales, MD, as they review the disease state of T2D, the role of GLP-1 in glucose regulation, guidelines on early use of GLP-1 RAs in T2D treatment, as well as dosing, administration, and the monotherapy data of a once daily GLP-1 RA for T2D treatment.

6 total episodes available

Deep-dive analytics for The 411 on a GLP-1

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is The 411 on a GLP-1?

Join series hosts Dr. Jim Gavin, Clinical Professor of Medicine at Emory University and Chief Medical Officer at Healing Our Village, in Atlanta, GA; Dr. Jennifer Goldman, Professor of Pharmacy at Massachusetts College of Pharmacy, in Boston, MA, and Clinical Pharmacist at Well Life Medical, in Peabody, MA, and other fellow leaders in the field of diabetes as they tackle some of the challenges we face when treating T2D. Topics of discussion include the disease state of T2D, the role of GLP-1 in glucose regulation, guidelines on early use of GLP-1 RAs in T2D treatment, as well as the mechanism of action, dosing and administration, efficacy and safety profiles, handling and storage, and education of patients and pharmacists for a once-daily GLP-1 RA for adults with T2D.

This podcast series is sponsored by Novo Nordisk and is intended for clinicians.

How often does this podcast release new episodes?

This podcast updates inactive.

Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

No, this podcast does not typically feature guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.